Prevalence of Preexisting Cardiovascular Diseases in Prostate Cancer Patients and Cardiac Risks of Hormonal Therapy.
Abdullah Mousa AlzahraniHend Al ShamsiMohammed Al MomenAbdullah Al FluijAshrafl Al Matar
Published in: Saudi journal of medicine & medical sciences (2024)
About one-fifth of the prostate cancer patients had preexisting CVDs. This study also found that luteinizing hormone-releasing hormone agonist could be a risk factor for new CVEs.